Australia markets closed

Surgery Partners, Inc. (SGRY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
25.83-0.62 (-2.34%)
At close: 04:00PM EDT
25.83 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.28B
Enterprise value 6.26B
Trailing P/E 2.58k
Forward P/E 25.58
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.16
Price/book (mrq)1.67
Enterprise value/revenue 2.24
Enterprise value/EBITDA 13.15

Trading information

Stock price history

Beta (5Y monthly) 2.76
52-week change 3-32.38%
S&P500 52-week change 326.49%
52-week high 345.79
52-week low 322.05
50-day moving average 326.82
200-day moving average 330.02

Share statistics

Avg vol (3-month) 3979.86k
Avg vol (10-day) 31.33M
Shares outstanding 5127.09M
Implied shares outstanding 6127.09M
Float 874.85M
% held by insiders 11.09%
% held by institutions 1108.89%
Shares short (30 Apr 2024) 48.94M
Short ratio (30 Apr 2024) 411.38
Short % of float (30 Apr 2024) 415.49%
Short % of shares outstanding (30 Apr 2024) 47.04%
Shares short (prior month 28 Mar 2024) 48.27M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.02%
Operating margin (ttm)12.60%

Management effectiveness

Return on assets (ttm)4.00%
Return on equity (ttm)4.76%

Income statement

Revenue (ttm)2.79B
Revenue per share (ttm)22.21
Quarterly revenue growth (yoy)7.70%
Gross profit (ttm)N/A
EBITDA 554.3M
Net income avi to common (ttm)600k
Diluted EPS (ttm)0.01
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)185.2M
Total cash per share (mrq)1.47
Total debt (mrq)3.17B
Total debt/equity (mrq)94.41%
Current ratio (mrq)1.71
Book value per share (mrq)15.57

Cash flow statement

Operating cash flow (ttm)260M
Levered free cash flow (ttm)149.59M